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Group B streptococcal bacteremia in elderly patients in Central TaiwanTo the Editor
Group B Streptococcus (GBS) is a major cause of sepsis, and an
occasional cause of serious infection in nonpregnant adults,
including the elderly.1 GBS infections are often associated with
considerable morbidity and mortality.2 Wang et al have reported
the mortality among elderly patients due to invasive GBS diseases
to be 35.1%;3 however, the data are still unclear. We analyzed theTable 1
Demographic and clinical characteristics of 55 patients with group B streptococcal bacte
Adults (18–65 years)
n 29
Age (yr), mean  SD 51.97  9.91
Gender, n (% male) 14 (45.2)
Length of stay (d) 18.14  16.90
Intensive care unit admissions (d), mean  SD 10.73  3.00
In-hospital mortality, n (%) 11 (37.9)
15-day mortality 6 (18.8)
30-day mortality 8 (27.5)
Underlying diseases, n (%)
Diabetes mellitus 10 (34.5)
Cancer 14 (48.3)
Liver cirrhosis 5 (17.2)
Diagnostic work-up
White cell count (10
ˇ
3/mm3) 12204.55  8758.59
C-reactive protein (mg/dL) 8.22  4.89
Systolic blood pressure (mmHg) 122.88  22.11




Source focus of infection, n (%)b
Skin and soft tissue 3 (10.4)
Pneumonia 2 (6.9)
Urinary tract 2 (6.9)
Pleural empyema 0
Septic arthritis 1 (3.4)
Central nervous system 1 (3.4)
Infective endocarditis 2 (6.9)
Others 2 (6.9)
Initial effective antibiotic usage, n (%) 27 (93.1)
Antibiotics generations used at diagnosis, n (%)c
First generation 20 (74.1)
Second generation 7 (25.9)
Third generation 0
a Calculated by Chi-square test or Fisher’s exact test when appropriate.
b The source focus of infection was deﬁned by presenting symptoms in the medical r
image studies, or bacterial cultures from body sites. Sources included heart valve (natu
urinary tract, intra-abdominal, and miscellaneous. Primary bacteremia was deﬁned wh
Secondary bacteremia was deﬁned in cases where group B Streptococcus in the blood w
c First-generation antibiotics: ampicillin, bactrim, cefazoline, doxycycline, gentamicin,
biotics: ampicillin–cluvnate (Augmentin), amikacin, cefmetazole, cefonicid, cefuroxime, c
Third-generation antibiotics: ceﬁxime, cefotaxime, ceftazidime, ceftizoxime, ceftriaxone,
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http://dx.doi.org/10.1016/j.jcgg.2012.10.001clinical features of patients with GBS bacteremia at Changhua
Christian Hospital (CCH), which is an 1800-bed teaching hospital
in central Taiwan, with a focus on the clinical presentations of
elderly patients.
We conducted a cross-sectional retrospective review of medical
records from all documented cases of GBS bacteremia at CCH from
January 1, 2001 through December 31, 2009. Cases with inadequate
clinical data or misidentiﬁed microbiological examinations,remia in the adult group (<65 years old) and the elderly group (65 years old).
Elderly (>65 years) All patients pa
26 55
76.54  7.02 63.59  15.07 <0.001
5 (19.2) 19 (34.5) 0.024
17.04  20.84 17.61  18.72 0.318
16.29  17.14 12.23  14.69 0.151
8 (30.8) 19 (34.5) 0.672
4 (15.4) 10 (17.7)
6 (23.1) 14 (25.4)
7 (26.9) 17 (30.9) 0.545
6 (23.1) 20 (36.4) 0.052
2 (7.7) 7 (12.7) 0.426
10,405.88  5846.74 11,420.51  7589.72 0.640
18.01  9.22 14.97  9.68 0.012
112.67  7.23 118.50  17.63 0.332
63.17  16.53 73.57  16.37 0.033
8 (30.7) 24 (43.6) 0.026
18 (69.3) 31 (56.4) 0.367
5 (19.2) 8 (14.5)
4 (15.4) 6 (10.9)
3 (11.5) 5 (9.1)
2 (7.7) 2 (3.6)
2 (7.7) 3 (5.4)
1 (3.8) 2 (3.6)
1 (3.8) 3 (5.4)
0 2 (3.6)
23 (88.5) 50 (90.9) 0.659
18 (78.3) 38 (76)
3 (13.0) 10 (20)
2 (8.7) 2 (4)
ecords, related signs identiﬁed from physical examinations, positive ﬁndings from
re valve or prosthetic valve), respiratory tract, skin and soft tissue, bone and joint,
en no focus of infection could be identiﬁed after thorough studies at admission.
as from a distinct site of infection.
oﬂoxacin, penicillin, pipemidic acid, oxacillin, clindamycin. Second-generation anti-
iproﬂoxacin, piperacillin, tobramycin, ampicillin–sulbactam (Unasyn), cefmetazole.
imipenem–cilastatin (Tienam), vancomycin, cefepime, ﬂomoxef, levoﬂoxacin.
ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Kaplan-Meier Survival Rate 
Infection sources Dth/N 15 days 1 month 2 months 3 months p-value
Primary 13/22 86.36 81.82 77.27 68.18 0.001
95% C.I.  72-100 65.7-97.9 59.8-94.8 48.7-87.6  
N  19 18 17 15  
Secondary 5/31 96.77 96.77 96.7  93.55  
95% C.I.  90.6-100 90.6-100 90.6-100 84.9-100  
N  30 30 30 29  
Notes
1. p-value by Log-rank test 
2. Follow-up was from diagnosis of GBS infection until death (or 2010.09.15) 
Fig. 1. The Kaplan-Meier Survival Rate for different infection sources.
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signiﬁcance, were excluded. Patients above 65 years of age were
deﬁned as elderly, and those in the 18–65 age group as adults.
Bacteremia and the source of infection was deﬁned accordingly.
We also deﬁned successive generations of antibiotics.
Fifty-ﬁve cases of GBS bacteremia were analyzed (Table 1), of
which 19 (34.5%) occurred in males. The overall incidence rate
was 24.3 cases per 100,000 admissions to CCH, with an overall
case-fatality rate of 34.5% (19/55). Case-mortality rates were
37.9% in adults and 30.8% in elderly patients, with no signiﬁcant
difference (p ¼ 0.672). Table 1 shows the demographic and clinical
characteristics of the 55 patients, broken down by age group.
The most common foci of primary infection in adults and the
elderly were: primary bacteremia (55.2% vs. 30.7%; p ¼ 0.026), fol-
lowed by skin and soft tissue infection (10.4% vs. 19.2%; p ¼ 0.367).
There was no signiﬁcant between-group difference for diabetes
mellitus or liver cirrhosis; however, signiﬁcantly more adult than
elderly patients had cancer (48.3% vs. 23.1%; p ¼ 0.052). At diag-
nosis, adult patients had signiﬁcantly lower C-reactive protein
(CRP) levels (8.22  4.89 vs. 18.01  9.22; p ¼ 0.013, mean, SD)
and higher diastolic blood pressure (81.38  11.83 vs.63.17  16.53; p ¼ 0.033) than the elderly cohort. The most
common source foci of infection in elderly group were skin and
soft tissue infection, pneumonia, and urinary tract infection.
Multivariate Cox proportional hazards regression analysis for
the 19 patients who died showed source foci of infection (primary
bacteremia) to be a major risk factor (Fig. 1). A lack of a signiﬁcant
source focus of infection (primary bacteremia) and noneradication
of infective foci predicted higher mortality. Isolates from all 55
cases were susceptible to penicillin and vancomycin. Rates of non-
susceptibility to erythromycin and clindamycin were 44.1% (30/55)
and 48.5% (33/55), respectively. Inadequate use of antibiotics at
diagnosis may be the cause of some mortality; however, there
were no signiﬁcant differences in initial effective antibiotic usage
between adult and elderly patients (93.1% vs. 88.5%; p ¼ 0.659).
We found the source foci of infection to be more apparent in
elderly than adult patients, which suggests that elderly individuals
should be carefully screened for invasive GBS. GBS-infected
patients above age 65 years usually have initial CRP levels
exceeding 18 mg/dL and diastolic blood pressure below
80mmHg. Apart from age, other known risk factors for GBS are dia-
betes mellitus, malignancy, and cirrhosis of the liver;4 these were
common among both groups in this study but their occurrence
differed from patient to patient. The case-mortality rate of GBS
bacteremia in the elderly group (30.8%) was lower than the 35.1%
mortality rate of invasive GBS diseases among elderly patients re-
ported by Wang.3 US national surveillance data5 have shown
a case-fatality rate of 13.1% for people over 65 years of age. In
conclusion, invasive GBS in elderly patients warrants particular
attention. Primary bacteremia and failure to eradicate foci of infec-
tion predict higher mortality.References
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